Jonathan Fawcett

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Robin Kate Kelley, Lorenza Rimassa, Ann‐Lii Cheng et al. · The Lancet Oncology · 2022 · 494 citations · Full text

Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes

Jonathan Fawcett, Claire Holness, Lindsey Needham et al. · Nature · 1992 · 345 citations

Inflammation, Cytokine, Third Ligand +10

Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

Stephen B. Fox, Jonathan Fawcett, David G. Jackson et al. · PubMed · 1994 · 313 citations

Immunology, Immunoediting, Pathology +18

Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family

Claire Holness, R.P. da Silva, Jonathan Fawcett et al. · Journal of Biological Chemistry · 1993 · 215 citations · Full text

Immunology, Cytoskeleton, Cellular Physiology +18

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

Stuart McPherson, Julie R. Jonsson, Gary Cowin et al. · Journal of Hepatology · 2009 · 175 citations

Metabolic Associated Steatohepatitis, Fibrosis, Hepatology +10